<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02823743</url>
  </required_header>
  <id_info>
    <org_study_id>VGR-2170</org_study_id>
    <nct_id>NCT02823743</nct_id>
  </id_info>
  <brief_title>RECAB-ASA; Treatment of Recurrent Abortion With Aspirin</brief_title>
  <acronym>RECAB-ASA</acronym>
  <official_title>Treatment of Recurrent Abortion With Low Dose Aspirin - a Randomized Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vastra Gotaland Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Göteborg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to examine whether treatment with 75 mg aspirin daily compared with
      placebo could reduce the risk for a new miscarriage. The treatment starts when the pregnancy
      is detected on transvaginal ultrasound (around gestational week 6+) and continues to week
      35/36. The study is a single center, randomized, placebo-controlled, double blind and
      stratified for age. 400 participants with the diagnosis idiopathic recurrent abortion are
      enrolled, 200 in each arm aspirin / placebo.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Live birth</measure>
    <time_frame>delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spontaneous abortion</measure>
    <time_frame>up to 22 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vaginal bleeding</measure>
    <time_frame>up to 42 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Premature delivery</measure>
    <time_frame>At delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intrauterine growth retardation, measured by ultrasound as percentage deviation</measure>
    <time_frame>up to 42 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preeclampsia</measure>
    <time_frame>up to 42 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy induced hypertension</measure>
    <time_frame>up to 42 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Placenta praevia</measure>
    <time_frame>up to 42 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perinatal mortality</measure>
    <time_frame>Third trimester and 28 days after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perinatal morbidity</measure>
    <time_frame>28 days after delivery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Abortion, Habitual</condition>
  <arm_group>
    <arm_group_label>Low dose aspirin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>75 mg aspirin orally daily from gestational week 7-35</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo pill orally daily from gestational week 7-35</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin</intervention_name>
    <description>Daily medication</description>
    <arm_group_label>Low dose aspirin</arm_group_label>
    <other_name>ASA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Daily intake</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  recurrent abortion (≤ 3 consecutive abortions in first trimester)

          -  unknown etiology after work-up

          -  willingness to be randomized

        Exclusion Criteria:

          -  previous participation in the study

          -  known cause of recurrent abortion, requiring specific management

          -  age ≥ 40

          -  BMI above 35

          -  IVF pregnancy if the reason for IVF was recurrent spontaneous abortion

          -  ongoing treatment with aspirin for other reason

          -  Sjoegren syndrome
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annika Strandell, Ass.prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Göteborg University</affiliation>
  </overall_official>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2016</study_first_submitted>
  <study_first_submitted_qc>July 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2016</study_first_posted>
  <last_update_submitted>July 5, 2016</last_update_submitted>
  <last_update_submitted_qc>July 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Göteborg University</investigator_affiliation>
    <investigator_full_name>Annika Strandell</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>recurrent pregnancy loss, Habitual abortion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abortion, Habitual</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

